Heilongjiang, China

Mingda Sun



Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovations of Mingda Sun

Introduction

Mingda Sun is a notable inventor based in Heilongjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of chemical compounds. His work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Mingda Sun holds a patent for diaza-benzofluoranthrene compounds. This patent discloses a series of diaza-benzofluoranthrene compounds, particularly relating to a compound represented by formula (I), along with its pharmaceutically acceptable salts or tautomers. This invention is a testament to his innovative approach in the pharmaceutical industry.

Career Highlights

Mingda Sun is associated with Harbin Pharmaceutical Group Co., Ltd., specifically the General Pharmaceutical Factory. His role in this esteemed organization has allowed him to contribute to various projects that aim to enhance drug development and therapeutic solutions. His work is characterized by a commitment to quality and efficacy in pharmaceutical products.

Collaborations

Mingda Sun has collaborated with notable colleagues such as Shujie Yuan and Xinchun Yang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work in the pharmaceutical sector.

Conclusion

Mingda Sun's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds, showcasing the importance of innovation in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…